Vir Biotechnology Inc VIR:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:11 PM EDT
24.68quote price arrow up+0.03 (+0.12%)
Volume
22,341
Close
24.65quote price arrow down-0.23 (-0.92%)
Volume
967,036
52 week range
18.21 - 58.00
Loading...
  • Open24.54
  • Day High25.00
  • Day Low24.33
  • Prev Close24.88
  • 52 Week High58.00
  • 52 Week High Date12/20/21
  • 52 Week Low18.21
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap3.27B
  • Shares Out132.64M
  • 10 Day Average Volume1.32M
  • Dividend-
  • Dividend Yield-
  • Beta-0.4
  • YTD % Change-41.13

KEY STATS

  • Open24.54
  • Day High25.00
  • Day Low24.33
  • Prev Close24.88
  • 52 Week High58.00
  • 52 Week High Date12/20/21
  • 52 Week Low18.21
  • 52 Week Low Date05/12/22
  • Market Cap3.27B
  • Shares Out132.64M
  • 10 Day Average Volume1.32M
  • Dividend-
  • Dividend Yield-
  • Beta-0.4
  • YTD % Change-41.13

RATIOS/PROFITABILITY

  • EPS (TTM)8.03
  • P/E (TTM)3.07
  • Fwd P/E (NTM)-22.25
  • EBITDA (TTM)1.313B
  • ROE (TTM)80.15%
  • Revenue (TTM)2.108B
  • Gross Margin (TTM)91.33%
  • Net Margin (TTM)51.12%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vir Biotechnology Inc

Profile

MORE
Vir Biotechnology, Inc. is a commercial-stage immunology company focused on combining immunologic insights with technologies to treat and prevent serious infectious diseases. It has assembled four technology platforms focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid (siRNA), through internal development, collaborations, and acquisitions. The Company's pipeline consists of sotrovimab and other product candidates targeting COVID-19...
Vicki Sato Ph.D.
Independent Chairman of the Board
George Scangos Ph.D.
President, Chief Executive Officer, Director
Johanna Friedl-Naderer
Chief Operating Officer, Executive Vice President
Howard Horn
Chief Financial Officer, Secretary
Ann Hanly Ph.D.
Chief Technology Officer
Herbert Virgin M.D., Ph.D.
Executive Vice President - Research and Chief Scientific Officer
Address
499 Illinois St Ste 500
San Francisco, CA
94158-2521
United States

Top Peers

SYMBOLLASTCHG%CHG
NVAX
Novavax Inc
36.22-0.96-2.58%
EXEL
Exelixis Inc
19.33+0.11+0.57%
EXAS
Exact Sciences Corp
36.83-1.65-4.29%
MEDP
Medpace Holdings Inc
171.39-3.05-1.75%
PTCT
PTC Therapeutics Inc
51.45-0.65-1.25%